Hyponatremia in the Prevention of Hospitalized Patients Falls

Overview

Cross ecological quasi-experimental study to assess effectiveness of early intervention in the diagnosis and treatment of hyponatremia in the prevention of hospitalized patients´ falls.

Full Title of Study: “Effectiveness of Early Intervention in the Diagnosis and Treatment of Hyponatremia in the Prevention of Hospitalized Patients Falls”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Crossover Assignment
    • Primary Purpose: Prevention
    • Masking: None (Open Label)
  • Study Primary Completion Date: December 2016

Detailed Description

Effectiveness of early intervention in the diagnosis and treatment of hyponatremia in the prevention of hospitalized patients´ falls. Aims: 1. To assess the effectiveness of corrective activity of hyponatremia in falls reducing incidence. 2. To assess the cost-effectiveness ratio of the two proposed strategies: conventional treatment versus early intervention. Cross ecological quasi-experimental study. The project will take place in Gregorio Marañón Hospital (Madrid, Spain) in the following inpatient adult Units: Neurology, Rehabilitation 1, Geriatrics, Internal Medicine (Group A), Cardiology, Rehabilitation 2, Gastroenterology, Neurosurgery and Oncology (Group B). The estimated sample size for a confidence level of 95% (α = 0.05) and power of 90% (β = 0.010), taking into account a decrease in the incidence of falls of 20% restocking losses, is 124 patients per group (ie, the 124 patients receiving regular performance ** and 124 patients receiving the experimental intervention *, if necessary, by participant Unit). Data collection: In each of the study participants Units both interventions will be held. First the participants Units have been randomized in two groups (Group A: Neurology, Rehabilitation 1, Geriatrics, Internal Medicine; Group B: Cardiology, Rehabilitation 2, Gastroenterology, Neurosurgery and Oncology). All patients hospitalized in these Units will be potentially included. First of all, collaborators will give them an informed consent to ask for their participation. The interventions are: – Experimental intervention: early diagnosis, treatment of hyponatremia until resolution and valuation according to the Dynamic Gait Index test. Duration: 6 months – Habitual action: the usual pattern of work will be performed in all patients who enter. Duration: 6 months.

Interventions

  • Other: Early detection and treatment of hyponatremia
    • In the experimental group, hyponatremia will be diagnosed and treated early. Therefore, the researchers will review the patients’ sodium levels at admission and throughout their stay.
  • Other: No Intervention (SOC)
    • Usual pattern of work will be performed in all patients who enter in Hospital.

Arms, Groups and Cohorts

  • Experimental: Early hyponatremia diagnosis and treatment
    • The early diagnosis of hiponatremia is not a stándar procedure. In the experimental arm, hyponatremia will be diagnosed and treated early.
  • No Intervention: No intervention
    • Usual pattern of work will be performed in all patients who enter in Hospital. Duration: 6 months.

Clinical Trial Outcome Measures

Primary Measures

  • To evaluate the effectiveness of treatment of hyponatremia in reducing the incidence of falls.
    • Time Frame: 1 year
    • The effectiveness will be measured in terms of less incidence of falls

Secondary Measures

  • To evaluate the cost-effectiveness of the 2 strategies proposed: conventional treatment vs early intervention.
    • Time Frame: 1 year
    • The cost-effectiveness will be indirectly measured using Average cost per inpatient day

Participating in This Clinical Trial

Inclusion Criteria

  • Age >65 years – Admitted to a participating study unit – Wish to participate in the study and signature of informed consent. Exclusion Criteria:

  • Transfer of the patient to a unit not included in the study – Deterioration of the patient's condition to severe or extremely painful

Gender Eligibility: All

Minimum Age: 65 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Mª del Carmen Lobo Rodríguez
  • Collaborator
    • Fundación Mutua Madrileña
  • Provider of Information About this Clinical Study
    • Sponsor-Investigator: Mª del Carmen Lobo Rodríguez, Msc Nurse Research – Hospital General Universitario Gregorio Marañon
  • Overall Official(s)
    • Carmen Lobo-Rodriguez, pHd, Principal Investigator, carmen.lobo@salud.madrid.org

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.